Parnax Lab Board approves FY26 results, re-appoints Director Varia

Parnax Lab Limited's Board of Directors convened on May 28, 2026, to approve the Standalone & Consolidated Audited Financial Results for the quarter and year ended March 31, 2026. The Board also confirmed that the auditors expressed an unmodified opinion on the standalone financial results. Additionally, Mr. Yogesh K. Varia was re-appointed as a Non-Executive Independent Director for a second term of five consecutive years, effective from May 28, 2026, to May 27, 2031. This re-appointment is contingent upon approval from the company's members at the upcoming General Meeting. Mr. Varia brings over 40 years of experience in pharmaceutical and cosmetics manufacturing.